Skip to content

Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study

Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05592925
Acronym
MA
Enrollment
516
Registered
2022-10-25
Start date
2018-01-01
Completion date
2022-10-31
Last updated
2022-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer Stage, Lymph Node Metastasis

Keywords

gastric cancer, lymph node metastasis, maximum amplitude, prognostic factor

Brief summary

We initially selected a total of 1128 patients with primary gastric cancer who presented at Shandong Provincial Hospital between January 2018 and October 2022, and retrospectively collected their clinical and pathological data. And retrospectively analyzed preoperative baseline characteristics, preoperative laboratory tests, and postoperative pathological results for these patients

Interventions

DIAGNOSTIC_TESTcoagulation-related factors

We retrospectively evaluated the relationship between lymph node metastasis and coagulation-related factors in 516 patients with T4a stage gastric cancer.

Sponsors

Shandong Provincial Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. patients with primary gastric malignant tumors, 2. patients who underwent radical resection of gastric cancer, 3. patients with a postoperative pathology of adenocarcinoma or signet ring cell carcinoma according to the WTO pathological classification,

Exclusion criteria

1. patients who have distant metastases, such as liver or lung metastases, were found on preoperative ultrasound and computed tomography (CT) examinations, 2. patients who have received preoperative neoadjuvant chemotherapy, 3. patients who take anticoagulant drugs (such as aspirin) prior to surgery, 4. patients who had any previous coagulation disorder.

Design outcomes

Primary

MeasureTime frameDescription
Preoperative coagulation-related factors (MA values) of patientsThree yearsMA values(mm). Measure the data of preoperative MA values in 516 gastric cancer patients to see wether this indicator correlated with tumor stage in patients with gastric cancer.
Preoperative coagulation-related factors (platelet counts) of patientsThree yearsPlatelet counts(x10\^9/L). Measure the data of preoperative platelet counts in 516 gastric cancer patients to see wether this indicator correlated with tumor stage in patients with gastric cancer.
Preoperative coagulation-related factors (fibrinogen levels) of patientsThree yearsFibrinogen levels (g/L). Measure the data of preoperative fibrinogen levels in 516 gastric cancer patients to see wether this indicator correlated with tumor stage in patients with gastric cancer.
Preoperative coagulation-related factors (D-dimer) of patientsThree yearsD-dimer (mg/L). Measure the data of preoperative D-dimer in 516 gastric cancer patients to see wether this indicator correlated with tumor stage in patients with gastric cancer.
Postoperative pathological results of tumor T stage.Three yearsRecording the postoperative pathological tumor T stage in 516 patients with gastric cancer.
Postoperative pathological results of tumor N stage.Three years.Recording the postoperative pathological tumor N stage in 516 patients with gastric cancer.

Countries

China

Contacts

Primary ContactFeng Tian, Doctor
tianfeng@sdu.edu.cn18866102886
Backup ContactChangqing Jing, Doctor
jingchangqing@sdfmu.edu.cn15168888987

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026